{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["C-prenyl coumarins", "UPLC-ESI-QTOF-MS", "anti-inflammatory activity", "metabolomics"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34770967", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "03"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "29"}], "Language": ["eng"], "ELocationID": ["6558", "10.3390/molecules26216558"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "21", "PubDate": {"Year": "2021", "Month": "Oct", "Day": "29"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Metabolic Profile of C-Prenyl Coumarins Using Mass Spectrometry-Based Metabolomics.", "Abstract": {"AbstractText": ["C-prenyl coumarins (C-PYCs) are compounds with similar structures and various bioactivities, which are widely distributed in medicinal plants. Until now, the metabolic characterizations of C-PYCs and the relationship between metabolism and bioactivities remain unclear. In this study, ultra-performance chromatography electrospray ionization quadrupole time-of-flight mass spectrometry-based metabolomics (UPLC-ESI-QTOF-MS) was firstly used to determine the metabolic characterizations of three C-PYCs, including meranzin hydrate (MH), isomeranzin (ISM), and meranzin (MER). In total, 52 metabolites were identified, and all of them were found to be novel metabolites. Among these metabolites, 10 were from MH, 22 were from ISM, and 20 were from MER. The major metabolic pathways of these C-PYCs were hydroxylation, dehydrogenation, demethylation, and conjugation with cysteine, <i>N</i>-acetylcysteine, and glucuronide. The metabolic rate of MH was much lower than ISM and MER, which was only 27.1% in MLM and 8.7% in HLM, respectively. Additionally, recombinant cytochrome P450 (CYP) screening showed that CYP1A1, 2B6, 3A4, and 3A5 were the major metabolic enzymes involved in the formation of metabolites. Further bioactivity assays indicated that all of these three C-PYCs exhibited anti-inflammatory activity, but the effects of ISM and MER were slightly higher than MH, accompanied by a significant decrease in inflammatory cytokines transcription induced by lipopolysaccharide (LPS) in macrophages RAW 264.7. Taken together, the metabolic characterizations of the three C-PYCs suggested that the side chain of the prenyl group may impact the metabolism and biological activity of C-PYCs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Metabolomics and Drug-Induced Liver Injury, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China."}], "LastName": "Cheng", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Academician Workstation, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Ma", "ForeName": "Xiaofang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Metabolomics and Drug-Induced Liver Injury, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China."}], "LastName": "Zhao", "ForeName": "Qi", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Metabolomics and Drug-Induced Liver Injury, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China."}], "LastName": "Wang", "ForeName": "Chunyan", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Academician Workstation, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Yan", "ForeName": "Dongmei", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Metabolomics and Drug-Induced Liver Injury, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China."}], "LastName": "Li", "ForeName": "Fei", "Initials": "F"}], "GrantList": [{"GrantID": "jxsq2018102022", "Agency": "Double Thousand Program of Jiangxi Province", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Coumarins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["analysis", "metabolism"], "DescriptorName": "Coumarins"}, {"QualifierName": [], "DescriptorName": "Metabolomics"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Spectrometry, Mass, Electrospray Ionization"}, {"QualifierName": [], "DescriptorName": "Tandem Mass Spectrometry"}], "CoiStatement": "The authors have declared no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wang S., Bao Y.R., Li T.J., Yu T., Chang X., Yang G.L., Meng X.S. Mechanism of Fructus aurantii Flavonoids Promoting Gastrointestinal Motility: From Organic and Inorganic Endogenous Substances Combination Point of View. Pharmacogn. Mag. 2017;13:372\u2013377.", "ArticleIdList": ["PMC5551352", "28839359"]}, {"Citation": "Tan W.X., Li Y., Wang Y., Zhang Z.J., Wang T., Zhou Q., Wang X.Y. Anti-coagulative and gastrointestinal motility regulative activities of Fructus aurantii Immaturus and its effective fractions. Biomed. Pharmacother. 2017;90:244\u2013252. doi: 10.1016/j.biopha.2017.03.060.", "ArticleIdList": ["10.1016/j.biopha.2017.03.060", "28363170"]}, {"Citation": "Bai Y.F., Wang S.W., Wang X.X., Weng Y.Y., Fan X.Y., Sheng H., Zhu X.T., Lou L.J., Zhang F. The flavonoid-rich Quzhou Fructus aurantii extract modulates gut microbiota and prevents obesity in high-fat diet-fed mice. Nutr. Diabetes. 2019;9:30. doi: 10.1038/s41387-019-0097-6.", "ArticleIdList": ["10.1038/s41387-019-0097-6", "PMC6811639", "31645541"]}, {"Citation": "Huang Y.T., Wang G.F., Chen C.F., Chen C.C., Hong C.Y., Yang M.C. Fructus aurantii reduced portal pressure in portal hypertensive rats. Life Sci. 1995;57:2011\u20132020. doi: 10.1016/0024-3205(95)02195-O.", "ArticleIdList": ["10.1016/0024-3205(95)02195-O", "7475952"]}, {"Citation": "Li X.R., Liang Q., Sun Y.J., Diao L., Qin Z., Wang W., Lu J.Z., Fu S.J., Ma B.L., Yue Z.J. Potential Mechanisms Responsible for the Antinephrolithic Effects of an Aqueous Extract of Fructus aurantii. Evid Based Complement Alternat Med. 2015:491409. doi: 10.1155/2015/491409.", "ArticleIdList": ["10.1155/2015/491409", "PMC4485555", "26170875"]}, {"Citation": "Zhang Y.J., Huang W., Huang X., Wang Y., Wang Z., Wang C., Zhong B.W., Sheng C.X., Wang B., Zhang S.F., et al. Fructus aurantii induced antidepressant effect via its monoaminergic mechanism and prokinetic action in rat. Phytomedicine. 2012;19:1101\u20131107. doi: 10.1016/j.phymed.2012.05.015.", "ArticleIdList": ["10.1016/j.phymed.2012.05.015", "22770641"]}, {"Citation": "Huang W., Huang X., Xing Z., Qiu X., Wang Y., Fan R., Liu W., Ren P., Liu Z., Zhou H. Meranzin hydrate induces similar effect to Fructus aurantii on intestinal motility through activation of H1 histamine receptors. J. Gastrointest. Surg. 2011;15:87\u201396. doi: 10.1007/s11605-010-1374-9.", "ArticleIdList": ["10.1007/s11605-010-1374-9", "21061180"]}, {"Citation": "Li L., Yu A.L., Wang Z.L., Chen K., Zheng W., Zhou J.J., Xie Q., Yan H.B., Ren P., Huang X. Chaihu-Shugan-San and absorbed meranzin hydrate induce anti-atherosclerosis and behavioral improvements in high-fat diet ApoE(-/-) mice via anti-inflammatory and BDNF-TrkB pathway. Biomed. Pharmacother. 2019;115:108893. doi: 10.1016/j.biopha.2019.108893.", "ArticleIdList": ["10.1016/j.biopha.2019.108893", "31022598"]}, {"Citation": "Liu X.F., Zhou J.L., Zhang T., Chen K., Xu M., Wu L., Liu J., Huang Y.K., Nie B.B., Shen X.X., et al. Meranzin hydrate elicits antidepressant effects and restores reward circuitry. Behav. Brain. Res. 2021;398:112898. doi: 10.1016/j.bbr.2020.112898.", "ArticleIdList": ["10.1016/j.bbr.2020.112898", "32905810"]}, {"Citation": "Xie Y., Huang X., Hu S.Y., Qiu X.J., Zhang Y.J., Ren P., Wang Y., Ji H., Zhang C.H., Xie W.B., et al. Meranzin hydrate exhibits anti-depressive and prokinetic-like effects through regulation of the shared \u03b12-adrenoceptor in the brain-gut axis of rats in the forced swimming test. Neuropharmacology. 2012;67:318\u2013325. doi: 10.1016/j.neuropharm.2012.10.003.", "ArticleIdList": ["10.1016/j.neuropharm.2012.10.003", "23063894"]}, {"Citation": "Xu G., Feng L.L., Song P.P., Xu F., Li A., Wang Y.B., Shen Y., Wu X.F., Luo Q., Wu X.X., et al. Isomeranzin suppresses inflammation by inhibiting M1 macrophage polarization through the NF-\u03baB and ERK pathway. Int. Immunopharmacol. 2016;38:175\u2013185. doi: 10.1016/j.intimp.2016.05.027.", "ArticleIdList": ["10.1016/j.intimp.2016.05.027", "27285671"]}, {"Citation": "Nalin R., Jacqueline A., Khye S.G., Anne D., Emile P., Paul B. Anti-mycobacterial activity of chemically defined natural substances from the Caribbean flora in Guadeloupe. FEMS Immunol. Med. Microbiol. 1998;20:267\u2013273.", "ArticleIdList": ["9626931"]}, {"Citation": "Shin E.J., Lee C., Sung S.H., Kim Y.C., Hwang B.Y., Lee M.K. Antifibrotic activity of coumarins from Cnidium monnieri fruits in HSC-T6 hepatic stellate cells. J. Nat. Med. 2011;65:370\u2013374. doi: 10.1007/s11418-010-0485-7.", "ArticleIdList": ["10.1007/s11418-010-0485-7", "21082271"]}, {"Citation": "Lv Q.Q., Yang X.N., Yan D.M., Liang W.Q., Liu H.N., Yang X.W., Li F. Metabolic profiling of dehydrodiisoeugenol using xenobiotic metabolomics. J. Pharm. Biomed. Anal. 2017;145:725\u2013733. doi: 10.1016/j.jpba.2017.07.045.", "ArticleIdList": ["10.1016/j.jpba.2017.07.045", "28806569"]}, {"Citation": "Yang X.N., Lv Q.Q., Zhao Q., Li X.M., Yan D.M., Yang X.W., Li F. Metabolic profiling of myrislignan by UPLC-ESI-QTOFMS-based metabolomics. RSC Adv. 2017;7:40131\u201340140. doi: 10.1039/C7RA06189G.", "ArticleIdList": ["10.1039/C7RA06189G"]}, {"Citation": "Xiao Y., Wang Y.K., Xiao X.R., Zhao Q., Huang J.F., Zhu W.F., Li F. Metabolic profiling of coumarins by the combination of UPLC-MS-based metabolomics and multiple mass defect filter. Xenobiotica. 2020;50:1076\u20131089. doi: 10.1080/00498254.2020.1744047.", "ArticleIdList": ["10.1080/00498254.2020.1744047", "32174209"]}, {"Citation": "Huang X., Guo Y., Huang W.H., Zhang W., Tan. Z.R., Peng J.B., Wang Y.C., Hu D.L., Ouyang D.S., Xiao J. Searching the cytochrome p450 enzymes for the metabolism of meranzin hydrate: A prospective antidepressant originating from Chaihu-Shugan-San. PLoS ONE. 2014;9:e113819. doi: 10.1371/journal.pone.0113819.", "ArticleIdList": ["10.1371/journal.pone.0113819", "PMC4245237", "25427198"]}, {"Citation": "Hu X., Huang W., Yang Y. Cytochrome P450 isoenzymes in rat and human liver microsomes associate with the metabolism of total coumarins in Fructus Cnidii. Eur. J. Drug Metab. Pharmacokinet. 2015;40:373\u2013377. doi: 10.1007/s13318-014-0219-4.", "ArticleIdList": ["10.1007/s13318-014-0219-4", "24993184"]}, {"Citation": "Cao G.Y., Yang X.W., Xu W., Li F. New inhibitors of nitric oxide production from the seeds of Myristica fragrans. Food. Chem. Toxicol. 2013;62:167\u2013171. doi: 10.1016/j.fct.2013.08.046.", "ArticleIdList": ["10.1016/j.fct.2013.08.046", "23994084"]}, {"Citation": "Kim H.N., Kim J.D., Yeo J.H., Son H.J., Park S.B., Eo H.J., Jeong J.B. Heracleum moellendorffii roots inhibit then Access production of pro-inflammatory mediators through the inhibition of NF-\u03baB and MAPK signaling, and activation of ROS/Nrf2/HO-1 signaling in LPS-stimulated RAW264. 7 cells. BMC Complement. Altern. Med. 2019;19:310.", "ArticleIdList": ["PMC6852938", "31718640"]}, {"Citation": "Han C., Yang J.K., Song P.Y., Wang X., Shi W.Y. Effects of Salviamil tiorrhiza polysaccharides on Lipopolysaccharide-Induced Inflammatory Factor Release in RAW 264.7 Cells. J. Interferon Cytokine Res. 2018;38:29\u201337. doi: 10.1089/jir.2017.0087.", "ArticleIdList": ["10.1089/jir.2017.0087", "29328882"]}, {"Citation": "Lee M., Rey K., Besler K., Wang C., Choy J. Immunobiology of Nitric Oxide and Regulation of Inducible Nitric Oxide Synthase, Results. Probl. Cell. Differ. 2017;62:181\u2013207.", "ArticleIdList": ["28455710"]}, {"Citation": "Manikandan P., Nagini S. Cytochrome P450 Structure, Function and Clinical Significance: A Review. Curr. Drug Targets. 2018;19:38\u201354. doi: 10.2174/1389450118666170125144557.", "ArticleIdList": ["10.2174/1389450118666170125144557", "28124606"]}, {"Citation": "Meyer U.A. Overview of enzymes of drug metabolism. J. Pharmacokinet. Biopharm. 1996;24:449\u2013459. doi: 10.1007/BF02353473.", "ArticleIdList": ["10.1007/BF02353473", "9131484"]}, {"Citation": "Lin J.H., Lu A.Y. Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol. Rev. 1997;49:403\u2013449.", "ArticleIdList": ["9443165"]}, {"Citation": "Alavijeh M.S., Palmer A.M. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines. IDrugs. 2004;7:755\u2013763.", "ArticleIdList": ["15334309"]}, {"Citation": "Zhang Z.P., Tang W. Drug metabolism in drug discovery and development. Acta Pharm. Sin. B. 2018;8:721\u2013732. doi: 10.1016/j.apsb.2018.04.003.", "ArticleIdList": ["10.1016/j.apsb.2018.04.003", "PMC6146880", "30245961"]}, {"Citation": "Fang Z.Z., Krausz K.W., Li F., Cheng J., Tanaka N., Gonzalez F.J. Metabolic map and bioactivation of the anti-tumour drug noscapine. Br. J. Pharmacol. 2012;167:1271\u20131286. doi: 10.1111/j.1476-5381.2012.02067.x.", "ArticleIdList": ["10.1111/j.1476-5381.2012.02067.x", "PMC3504993", "22671862"]}, {"Citation": "ZH Z.M., Wang Y.K., Yan D.M., Fang J.H., Xiao X.R., Zhang T., Cheng Y., Xu K.P., Li F. Metabolic profiling of tyrosine kinase inhibitor nintedanib using metabolomics. J. Pharm. Biomed. Anal. 2020;180:113045. doi: 10.1016/j.jpba.2019.113045.", "ArticleIdList": ["10.1016/j.jpba.2019.113045", "31887668"]}, {"Citation": "Korhonen R., Lahti A., Hamalainen M., Kankaanranta H., Moilanen E. Dexamethasome inhibits Inducible Nitric-Oxide Synthase Expression and Nitric Oxide Production by Destabilizing mRNA in Lipopolysaccharide-Treated Macrophages. Mol. Pharmacol. 2002;62:698\u2013704. doi: 10.1124/mol.62.3.698.", "ArticleIdList": ["10.1124/mol.62.3.698", "12181447"]}, {"Citation": "Wang Q.Q., Shan H., Li X.X., Gao H.W., Yang S.L. Anti-inflammatory effect and mechanism of verbascoside on LPS-induced RAW 264.7 cells. Chin. Tradit. Herb. Drug. 2020;51:4217\u20134222."}, {"Citation": "Tian Y., Zhou S.Q., Takeda R., Okazaki K., Sekita M., Sakamoto K. Anti-inflammatory activities of amber extract in lipopolysaccharide-induced RAW 264.7 macrophages. Biomed. Pharm. 2021;141:111854. doi: 10.1016/j.biopha.2021.111854.", "ArticleIdList": ["10.1016/j.biopha.2021.111854", "34229253"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "6"}, {"Year": "2021", "Month": "10", "Day": "25"}, {"Year": "2021", "Month": "10", "Day": "27"}, {"Year": "2021", "Month": "11", "Day": "13", "Hour": "1", "Minute": "12"}, {"Year": "2021", "Month": "11", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["34770967", "PMC8588418", "10.3390/molecules26216558", "molecules26216558"]}}], "PubmedBookArticle": []}